Impact of inappropriate antimicrobial therapy on outcome in patients with hospital-acquired pneumonia caused by Acinetobacter baumannii

被引:40
作者
Joung, Mi Kyong [1 ]
Kwon, Ki Tae [2 ]
Kang, Cheol-In [1 ]
Cheong, Hae Suk [3 ]
Rhee, Ji-Young [4 ]
Jung, Dong Sik [5 ]
Chung, Seung Min [1 ]
Lee, Jeong A. [1 ]
Moon, Soo-Youn [1 ]
Ko, Kwan Soo [7 ]
Chung, Doo Ryeon [1 ]
Lee, Nam Yong [6 ]
Song, Jae-Hoon [1 ,7 ]
Peck, Kyong Ran [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea
[2] Daegue Fatima Hosp, Div Infect Dis, Seoul, South Korea
[3] Konkuk Univ Hosp, Div Infect Dis, Seoul, South Korea
[4] Dankuk Univ Hosp, Div Infect Dis, Seoul, South Korea
[5] Dong A Univ Hosp, Div Infect Dis, Seoul, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea
[7] Asian Pacific Res Fdn Infect Dis ARFID, Seoul, South Korea
关键词
Acinetobacter baumannii; Hospital-acquired pneumonia; Inappropriate; Definitive antimicrobial therapy; VENTILATOR-ASSOCIATED PNEUMONIA; PROTECTED SPECIMEN BRUSH; CRITICALLY-ILL PATIENTS; NOSOCOMIAL PNEUMONIA; QUANTITATIVE CULTURE; MORTALITY; BACTEREMIA; RISK; INFECTIONS; RESISTANCE;
D O I
10.1016/j.jinf.2010.06.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The purpose of this study was to evaluate the impact of inappropriate antimicrobial therapy on the outcome of patients with hospital-acquired pneumonia (HAP) caused by Acinetobacter baumannii. Methods: All cases of HAP caused by A. baumannii from January 2000 to March 2006 at the Samsung Medical Center (Seoul, Korea) were analyzed retrospectively. Results: A total of 116 patients with clinically significant Acinetobacter HAP were enrolled. Among the A. baumannii isolates, 60.3% showed multi-drug resistance (MDR), 16.4% were found to have imipenem resistance, and 15.5% had pan-drug resistance (PDR). The mean APACHE II score of the patients was 22.3 +/- 7.9. The overall in-hospital and pneumonia-related mortality rates were 47.4% and 37.9%, respectively. The univariate analysis showed that the factors associated with pneumonia-related mortality were: MDR, PDR, high APACHE II score, inappropriate empirical antimicrobial therapy, and inappropriate definitive antimicrobial treatment (All p < 0.05). Among these, a high APACHE II score and inappropriate definitive antimicrobial therapy were found to be independent factors associated with a high mortality, after adjustment for other variables. Conclusions: The appropriate definitive antimicrobial therapy should be provided in patients with HAP caused by A. baumannii. (C) 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:212 / 218
页数:7
相关论文
共 23 条
[1]   Impact of Acinetobacter infection on the mortality of burn patients [J].
Albrecht, Michael A. ;
Griffith, Matthew E. ;
Murray, Clinton K. ;
Chung, Kevin K. ;
Horvath, Edward E. ;
Ward, John A. ;
Hospenthal, Duane R. ;
Holcomb, John B. ;
Wolf, Steven E. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (04) :546-550
[2]   Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients:: a matched cohort study [J].
Blot, S ;
Vandewoude, K ;
Colardyn, F .
INTENSIVE CARE MEDICINE, 2003, 29 (03) :471-475
[3]   IDENTIFICATION AND BIOTYPING OF CLINICAL ISOLATES OF ACINETOBACTER [J].
BOUVET, PJM ;
GRIMONT, PAD .
ANNALES DE L INSTITUT PASTEUR-MICROBIOLOGIE, 1987, 138 (05) :569-578
[4]   NOSOCOMIAL PNEUMONIA - A MULTIVARIATE-ANALYSIS OF RISK AND PROGNOSIS [J].
CELIS, R ;
TORRES, A ;
GATELL, JM ;
ALMELA, M ;
RODRIGUEZROISIN, R ;
AGUSTIVIDAL, A .
CHEST, 1988, 93 (02) :318-324
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]   Mortality risk factors of Acinetobacter baumannii bacteraemia [J].
Choi, JY ;
Park, YS ;
Kim, CO ;
Park, YS ;
Yoon, HJ ;
Shin, SY ;
Kim, YA ;
Song, YG ;
Yong, D ;
Lee, K ;
Kim, JM .
INTERNAL MEDICINE JOURNAL, 2005, 35 (10) :599-603
[7]   The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs [J].
Cosgrove, SE .
CLINICAL INFECTIOUS DISEASES, 2006, 42 :S82-S89
[8]   Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia [J].
Dupont, H ;
Mentec, H ;
Sollet, JP ;
Bleichner, G .
INTENSIVE CARE MEDICINE, 2001, 27 (02) :355-362
[9]   Outcome of postoperative pneumonia in the Eole study [J].
Dupont, H ;
Montravers, P ;
Gauzit, M ;
Veber, B ;
Pouriat, JL ;
Martin, C .
INTENSIVE CARE MEDICINE, 2003, 29 (02) :179-188
[10]   NOSOCOMIAL PNEUMONIA IN VENTILATED PATIENTS - A COHORT STUDY EVALUATING ATTRIBUTABLE MORTALITY AND HOSPITAL STAY [J].
FAGON, JY ;
CHASTRE, J ;
HANCE, AJ ;
MONTRAVERS, P ;
NOVARA, A ;
GIBERT, C .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (03) :281-288